AVATAXHER: An open-label, randomized, multicenter study investigating the addition of bevacizumab (B) to neoadjuvant trastuzumab (T) plus docetaxel (D) in patients with early stage HER2-positive breast cancer (HER2+BC) stratified according to PET change a

Affiliation auteurs!!!! Error affiliation !!!!
TitreAVATAXHER: An open-label, randomized, multicenter study investigating the addition of bevacizumab (B) to neoadjuvant trastuzumab (T) plus docetaxel (D) in patients with early stage HER2-positive breast cancer (HER2+BC) stratified according to PET change a
Type de publicationJournal Article
Year of Publication2014
AuteursCoudert BP, Pierga J-Y, Mouret-Reynier M-A, Kerrou K, Ferrero J-M, Petit T, Kerbrat P, Dupre P-F, Bachelot TDenis, Gabelle P, Giard S, Coeffic D, Bougnoux P, Prevost JBriac, Paintaud G, Thibault G, Hernandez J, Coudert M, Arnould L, Berriolo-Riedinger A
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume32
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2014.32.15_suppl.507